Corbus Pharmaceuticals Holdings Overview
Corbus Pharmaceuticals Holdings Target Price
Analysts' 12-month price predictions for CRBP.
Get informed when a big investor buys or sells
+ FollowShare Price
$8.18
Average Target Price
$38.50
370.9% upside
370.9% upside2 analysts in the last 4 months
High: $44 | Low: $33
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-22 | Mizuho SecuritiesGraig Suvannavejh | $44 | 438.2% upside |  |
| 2026-05-12 | JefferiesMaury Raycroft | $33 | 303.7% upside | |
| 2025-10-29 | Mizuho Securities | $39 | 377.1% upside | |
| 2025-10-20 | Piper Sandler | $51 | 523.9% upside | |
| 2025-10-20 | H.C. Wainwright | $40 | 389.3% upside | |
| 2024-12-02 | Piper SandlerBiren Amin | $35 | 328.1% upside | |
| 2024-10-21 | OppenheimerJeff Jones | $60 | 633.9% upside | |
| 2024-09-20 | B.Riley FinancialKalpit Patel | $40 | 389.3% upside | |
| 2024-09-13 | Mizuho SecuritiesGraig Suvannavejh | $74 | 805.2% upside | |
| 2024-08-07 | OppenheimerJeff Jones | $88 | 976.5% upside | |
| 2024-07-22 | H.C. WainwrightAndres Maldonado | $80 | 878.6% upside | |
| 2024-06-11 | RBC CapitalBrian Abrahams | $82 | 903.1% upside | |
| 2024-06-03 | OppenheimerJeff Jones | $80 | 878.6% upside | |
| 2024-05-20 | RBC CapitalBrian Abrahams | $77 | 841.9% upside | |
| 2024-03-06 | JefferiesMaury Raycroft | $46 | 462.7% upside | |